Page last updated: 2024-10-28

hydroxychloroquine and Brachial Plexopathy

hydroxychloroquine has been researched along with Brachial Plexopathy in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Recurrent attacks of painful brachial plexopathy may warrant careful evaluation for underlying SLE with a premise of therapeutic benefit."2.82Recurrent brachial plexopathy as initial presentation of systemic lupus erythematosus: A case report and review of the literature. ( Ali, S; Bonilla, E; El-Dokla, AM; Perl, A, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
El-Dokla, AM1
Bonilla, E1
Ali, S1
Perl, A1

Reviews

1 review available for hydroxychloroquine and Brachial Plexopathy

ArticleYear
Recurrent brachial plexopathy as initial presentation of systemic lupus erythematosus: A case report and review of the literature.
    Lupus, 2022, Volume: 31, Issue:4

    Topics: Adult; Brachial Plexus Neuropathies; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, System

2022